TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14636090

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Exercise (HRE) - 5 squats at 85% of 1 repetition maximum (1RM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no-HRE)
Number of subjects: 8
Study: 11769903

Group type: EXPERIMENTAL
Intervention: Token exchange reinforcement technique
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Verbal praise paired with token exchange reinforcement technique
Number of subjects: 5
Study: 9403034

Group type: EXPERIMENTAL
Intervention: Cruciferous vegetables
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-cruciferous vegetables
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: NAT2 rapid phenotype
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GSTM1- subjects
Number of subjects: 8
Study: 8240477

Group type: EXPERIMENTAL
Intervention: EMLA cream over the proposed epidural site for a minimum period of 5 min (mean 9.1 min)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Skin bleb and subcutaneous injection of lignocaine 2% (1 ml)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Skin bleb with additional lignocaine 2% (2 ml) infiltrated into the supra‐ and interspinous ligaments using a 23 G needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 2826064

Group type: EXPERIMENTAL
Intervention: Oxprenolol (80 mg orally)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Terbutaline (0.5 mg subcutaneous)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 6
Study: 31415451

Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 30342638

Group type: EXPERIMENTAL
Intervention: Family medicine clerkships
Number of subjects: 738

Group type: COMPARATOR
Intervention: Obstetrics and gynecology clerkships
Number of subjects: 738

Group type: COMPARATOR
Intervention: Internal medicine clerkships
Number of subjects: 738
Study: 28636754

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 26204387

Group type: EXPERIMENTAL
Intervention: Liposome bupivacaine (2-310 mg)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Bupivacaine HCl (75-125 mg)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Liposome bupivacaine
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Bupivacaine HCl
Number of subjects: 575
Study: 24252583

Group type: EXPERIMENTAL
Intervention: RE leading to failure (3 sets of 10 repetitions maximum)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RE not to failure (60% of 10-RM, 3 sets of 10 repetitions)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (40 minutes of seated rest)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60% of 10-RM and 10-RM sessions
Number of subjects: 10
Study: 20595155

Group type: EXPERIMENTAL
Intervention: Ciclesonide (160 μg s.i.d.)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fluticasone (100 μg b.i.d.)
Number of subjects: 37
Study: 18291270

Group type: EXPERIMENTAL
Intervention: One-visit root canal therapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Two-visit root canal therapy with calcium hydroxide/chlorhexidine paste dressing
Number of subjects: 97
Study: 16603430

Group type: EXPERIMENTAL
Intervention: Chinese herbal preparation
Number of subjects: 97
Study: 12959906

Group type: EXPERIMENTAL
Intervention: Active collision production
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imposed collision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imposed collision with visual feedback
Number of subjects: 0
Study: 10722988

Group type: EXPERIMENTAL
Intervention: Intervention clinics that implemented a preventive services delivery system
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intervention clinics that did not implement a preventive services delivery system
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IMPROVE project and managed care organizations' efforts
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 22
Study: 8958016

Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound (CDUS) and power flow imaging
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (benign and malignant adrenal masses)
Number of subjects: 47
Study: 29613944

Group type: EXPERIMENTAL
Intervention: Active rTMS (10-Hz stimulation, 20 daily treatments)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Baseline quality of episodic memory
Number of subjects: 84
Study: 29284438

Group type: EXPERIMENTAL
Intervention: IMPaCT Therapy
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: IMPaCT Therapy (>180 min)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 406
Study: 26268913

Group type: EXPERIMENTAL
Intervention: Cranberry (500 mg daily for 6 months)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Cranberry
Number of subjects: 182
Study: 23384111

Group type: EXPERIMENTAL
Intervention: Silicone gel applied to half of the chest scar for three months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (untreated half of the chest scar)
Number of subjects: 20
Study: 21237406

Group type: EXPERIMENTAL
Intervention: Manipulation group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mobilization group
Number of subjects: 100

Group type: COMPARATOR
Intervention: No-pop group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Multiple-pop group
Number of subjects: 100
Study: 18327093

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg and Delapril 30 mg
Number of subjects: 314

Group type: COMPARATOR
Intervention: Losartan 50 mg and Hydrochlorothiazide 12.5 mg
Number of subjects: 314
Study: 15996001

Group type: EXPERIMENTAL
Intervention: DMSO(2) concentration in plasma from patients with MAT I/III deficiency
Number of subjects: 4

Group type: COMPARATOR
Intervention: DMSO(2) concentration in cerebrospinal fluid (CSF) and plasma
Number of subjects: 4
Study: 12239448

Group type: EXPERIMENTAL
Intervention: Stepwise hook extension technique for radiofrequency ablation (RFA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Full extension method for radiofrequency ablation (RFA)
Number of subjects: 20
Study: 10321152

Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 8938004

Group type: EXPERIMENTAL
Intervention: Illusory line motion with an interstimulus interval (ISI) of a few hundred milliseconds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contrast polarity manipulation (dots brighter than background vs. dots darker and lines brighter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Display size manipulation (two, four, or eight pairs of dots and lines)
Number of subjects: 0
Study: 1890269

Group type: EXPERIMENTAL
Intervention: 8‐methoxypsoralen (8‐MP) at a dose of 10 mg followed by UVA irradiation (1 joule/cm2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVA irradiation alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 8‐MP plus UVA irradiation (increasing doses from 10 to 30 mg)
Number of subjects: 0
Study: 6754210

Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-dose Methyldopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-dose Propranolol
Number of subjects: 0
Study: 31308497

Group type: EXPERIMENTAL
Intervention: Exchange-only qubit encoded in a subsystem of three coupled electron spins
Number of subjects: 0
Study: 27859337

Group type: COMPARATOR
Intervention: Ticagrelor 60 mg twice daily
Number of subjects: 20942

Group type: COMPARATOR
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 20942

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 20942
Study: 27195511

Group type: EXPERIMENTAL
Intervention: ET (exercise training)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ET+IL (exercise training with inspiratory load)
Number of subjects: 15
Study: 23668847

Group type: EXPERIMENTAL
Intervention: Infrastructure for walking
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Access to services
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: MVPA
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Self-reported walking
Number of subjects: 434
Study: 23168147

Group type: EXPERIMENTAL
Intervention: Glove finger-coated polyvinyl acetate pack
Number of subjects: 30

Group type: COMPARATOR
Intervention: PA pack (Merocel; Medtronic Xomed)
Number of subjects: 30
Study: 19384691

Group type: EXPERIMENTAL
Intervention: Combinations of sorafenib and erlotinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (active standard treatment)
Number of subjects: 0
Study: 18075941

Group type: EXPERIMENTAL
Intervention: Experimental supported employment program
Number of subjects: 1273

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1273
Study: 15234027

Group type: COMPARATOR
Intervention: Once-daily radiotherapy (q.d. RT) - 50.4 Gy in 28 fractions
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Twice-daily radiotherapy (b.i.d. RT) - 24 Gy in 16 fractions, a 2.5-week break, and 24 Gy in 16 fractions
Number of subjects: 261
Study: 11907636

Group type: EXPERIMENTAL
Intervention: Amiodarone (600 mg/d)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Amiodarone (200 mg/d)
Number of subjects: 95
Study: 9270900

Group type: EXPERIMENTAL
Intervention: Quetiapine (75, 150, 300, 600, or 750 mg daily)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Quetiapine (300 mg daily)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Haloperidol (12 mg daily)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Quetiapine (all doses)
Number of subjects: 361
Study: 7894807

Group type: EXPERIMENTAL
Intervention: Granuflex Extra Thin
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional dressing (perforated film absorbent dressing)
Number of subjects: 96
Study: 3365008

Group type: EXPERIMENTAL
Intervention: Soya based substitute
Number of subjects: 487

Group type: COMPARATOR
Intervention: Cows' milk preparations
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Breast feeding
Number of subjects: 487
Study: 31448802

Group type: EXPERIMENTAL
Intervention: Steam roller maneuver (group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No steam roller maneuver (group 1)
Number of subjects: 40
Study: 28585932

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Education-based placebo intervention
Number of subjects: 81
Study: 25266695

Group type: EXPERIMENTAL
Intervention: PAG training (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Active control (CON, n=11)
Number of subjects: 23
Study: 23425819

Group type: EXPERIMENTAL
Intervention: Talactoferrin 1.5g every 8 hrs for up to 28 days
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Talactoferrin
Number of subjects: 194
Study: 21190079

Group type: EXPERIMENTAL
Intervention: Central HER2 evaluation
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: HER2 mRNA expression
Number of subjects: 278

Group type: COMPARATOR
Intervention: Local HER2 evaluation
Number of subjects: 278
Study: 18032739

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 808

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: abciximab (wake-up cohort)
Number of subjects: 808
Study: 17068892

Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 59

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 59
Study: 12607650

Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose: 3 x 10(4) KIU/kg plus a bolus of 5 x 10(5) KIU)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose)
Number of subjects: 60
Study: 8723579

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 300 IU/kg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 600 IU/kg
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 1649575

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (up to 3,200 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 104
Study: 6631803

Group type: EXPERIMENTAL
Intervention: manual aural toilet followed by aural drops
Number of subjects: 26

Group type: COMPARATOR
Intervention: drops only
Number of subjects: 26
Study: 30866967

Group type: EXPERIMENTAL
Intervention: Core Training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Core + Facilitation
Number of subjects: 10
Study: 30145671

Group type: EXPERIMENTAL
Intervention: Silver-alloy suprapubic catheter
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard suprapubic catheter
Number of subjects: 288
Study: 27959709

Group type: EXPERIMENTAL
Intervention: Centrifugal-flow pump
Number of subjects: 294

Group type: COMPARATOR
Intervention: Axial-flow pump
Number of subjects: 294
Study: 26210096

Group type: EXPERIMENTAL
Intervention: Laser Navigation System (LNS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 58
Study: 23241003

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg twice a day for 2 weeks, then 50 mg 3 times a week for 10 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 21909481

Group type: EXPERIMENTAL
Intervention: Steri‐Oss rubber matrices
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Branemark gold matrices
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Southern plastic matrices
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Straumann gold matrices
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Southern gold/platinum, Branemark gold, Southern plastic matrices
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overdentures
Number of subjects: 106
Study: 19843671

Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: MTHFR T allele
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: MTR 2756GG genotype
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: DNMT3b C‐‐>T (rs406193) polymorphism
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: EHMT2 G‐‐>A (rs535586) polymorphism
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: MTR A2756G
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: MTRR A66G
Number of subjects: 659
Study: 16905695

Group type: EXPERIMENTAL
Intervention: Multipolar electrocoagulation (MPEC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Argon plasma coagulation (APC)
Number of subjects: 35
Study: 15659891

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of ketorolac
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of oxybutynin
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of alkalinized lidocaine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control solution (0.9% sodium chloride)
Number of subjects: 42
Study: 11534420

Group type: COMPARATOR
Intervention: OCA‐7 (omeprazole 20 mg b.i.d., amoxycillin 1 gr b.i.d., clarithromycin 500 mg b.i.d.)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: RBCA (ranitidine bismuth citrate 400 mg b.i.d., amoxicillin 1 gr b.i.d., clarithromycin 500 mg b.i.d.)
Number of subjects: 200
Study: 9574474

Group type: EXPERIMENTAL
Intervention: Spa therapy (Group 2, n = 74)
Number of subjects: 220

Group type: COMPARATOR
Intervention: No spa therapy (Group 3, n = 74)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Spa therapy (Group 1, n = 72)
Number of subjects: 220
Study: 8160893

Group type: EXPERIMENTAL
Intervention: Doubly labeled water (DLW) method
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intake balance (I‐B) method
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Comparison of DLW and I‐B methods
Number of subjects: 6
Study: 3342283

Group type: EXPERIMENTAL
Intervention: Sustained-release tablets (T)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sustained-release microgranules (MG)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-protein test meal with T
Number of subjects: 8
Study: 31893475

Group type: EXPERIMENTAL
Intervention: Articles published in the journal
Number of subjects: 132
Study: 29273732

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) counseling session (90 minutes)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine procedures (Control)
Number of subjects: 80
Study: 26264474

Group type: EXPERIMENTAL
Intervention: TVT (tension-free vaginal tape)
Number of subjects: 140

Group type: COMPARATOR
Intervention: TVT-O (inside-out transobturator tape)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 140
Study: 26016859

Group type: EXPERIMENTAL
Intervention: 250 mg magnesium oxide
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 22456691

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (12-week dietary weight-loss programme)
Number of subjects: 49
Study: 21999623

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg bolus prior to surgery)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fibrin spray (10 mL during surgery)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (neither treatment)
Number of subjects: 66
Study: 18782316

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment (MU)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Vehicle (SU)
Number of subjects: 134
Study: 16928979

Group type: EXPERIMENTAL
Intervention: FRISK score based on multiple-site BMD measurements and risk factors
Number of subjects: 679

Group type: COMPARATOR
Intervention: FRISK score
Number of subjects: 679
Study: 14711063

Group type: EXPERIMENTAL
Intervention: Weight loss strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention trials
Number of subjects: 0
Study: 10844933

Group type: EXPERIMENTAL
Intervention: Distal lesions (neoplastic lesions in the distal colon)
Number of subjects: 3268

Group type: EXPERIMENTAL
Intervention: Proximal lesions (neoplastic lesions in the proximal colon)
Number of subjects: 3268

Group type: EXPERIMENTAL
Intervention: Both distal and proximal lesions
Number of subjects: 3268

Group type: EXPERIMENTAL
Intervention: Synchronous proximal lesions
Number of subjects: 3268

Group type: EXPERIMENTAL
Intervention: Nonadvanced lesion in the distal colon
Number of subjects: 3268

Group type: EXPERIMENTAL
Intervention: Advanced lesion in the distal colon
Number of subjects: 3268
Study: 1342306

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 1214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1214
Study: 6102677

Group type: EXPERIMENTAL
Intervention: Intraventricular gentamicin plus systemic antimicrobial agents
Number of subjects: 52

Group type: COMPARATOR
Intervention: Systemic ampicillin and gentamicin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intraventricular gentamicin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 52
Study: 29968519

Group type: EXPERIMENTAL
Intervention: WM training group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 52
Study: 31067131

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training at least three times per week
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Handgrip isometric training five times weekly
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo-handgrip
Number of subjects: 75
Study: 27564409

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg added to allopurinol
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg added to allopurinol
Number of subjects: 603

Group type: COMPARATOR
Intervention: Allopurinol alone (Control)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg and 400 mg added to allopurinol
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg
Number of subjects: 603
Study: 25829346

Group type: EXPERIMENTAL
Intervention: Combination therapy (bevacizumab plus dexamethasone delivery system)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bevacizumab monotherapy
Number of subjects: 30
Study: 23891461

Group type: EXPERIMENTAL
Intervention: Buprenorphine therapy with escitalopram treatment for depressive symptoms
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 21521728

Group type: COMPARATOR
Intervention: Angiotensin receptor blockers
Number of subjects: 147020
Study: 19297377

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 17074798

Group type: EXPERIMENTAL
Intervention: 200 mg voriconazole twice daily (BID) (400-mg BID loading doses on the first day), n = 16
Number of subjects: 23

Group type: COMPARATOR
Intervention: Matching placebo, n = 7
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 200 mg voriconazole twice daily (BID) with methadone
Number of subjects: 23
Study: 16652380

Group type: EXPERIMENTAL
Intervention: 8‐week program of clinic‐based or self‐administered behavioral training
Number of subjects: 359
Study: 14613070

Group type: EXPERIMENTAL
Intervention: End of Life Nursing Education Consortium (ELNEC) education package along with experiential learning (hospice, funeral home, anatomy laboratory, role play)
Number of subjects: 0
Study: 10418181

Group type: EXPERIMENTAL
Intervention: Prefilled, disposable insulin pen injector (Novolet)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional syringes
Number of subjects: 19
Study: 7776075

Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 100